MRK Stock: The Grand Daddy of Pharma

The pharma legend is a good bet for income investors. Right now, Merck (NYSE: MRK), this nation’s second biggest pharmaceutical maker, is a curious animal: a value stock that’s priced like a growth stock. At $58.72, where the stock closed Thursday, Merck shares were trading at 39 times trailing 12-month earnings, compared to an average … Continue reading MRK Stock: The Grand Daddy of Pharma

Is it Time to Rescue this Dividend Dog?

They’re called dividend dogs. These are companies the markets hate – yet deliver attractive dividend income and give us the opportunity for a significant stock price increase as well. If you’ve never heard of dividend dogs, you may be familiar with the Dogs of the Dow – a portfolio strategy based on buying companies with … Continue reading Is it Time to Rescue this Dividend Dog?

IBM Stock Chart Analysis

International Business Machines (NYSE: IBM) appeared on my bullish scan the other night due to the stochastic lines making a bullish crossover. At first glance, I didn’t think the setup looked all that great, but then I noticed how the previous crossovers that occurred on the daily chart with the readings in oversold territory had … Continue reading IBM Stock Chart Analysis

Why Tomorrow May Decide the Fate of Stocks in 2014

It hasn’t been a good first month for stocks. As of this morning’s market open, the S&P 500 is down more than 3.5% in January. Ordinarily a 3.5% pullback would be no cause for concern – especially considering that stocks entered the month near all-time highs. But history tells us that January is different. Yale … Continue reading Why Tomorrow May Decide the Fate of Stocks in 2014

3 Investing Lessons Learned From 2013

Editor’s Note: Yesterday I discussed three stocks that helped the 100% Letter advisory service outperform the Russell 2000 Small Cap Index by 43% in 2013. Today, I’ll briefly discuss three lessons learned in 2013 that can help growth investors outperform again in 2014. It is possible to double your money in 18 months. This is … Continue reading 3 Investing Lessons Learned From 2013

3 Great Stocks That Helped Us Outperform By 43%

One of the great myths of the financial newsletter industry is that every editor outperforms the market. It is, of course, not true. Despite all the claims, there’s no way every newsletter generates superior returns. This is not to say that some newsletters don’t outperform. Many do. And fortunately for subscribers to the 100% Letter … Continue reading 3 Great Stocks That Helped Us Outperform By 43%

Will Q4 Earnings Give Stocks Another Boost?

U.S. markets seem to be suffering from a post-New Year’s hangover after celebrating a banner 2013. Stocks have fallen each of the first three trading days to start 2014. It’s the first time they’ve done that in a month. At this point, Wall Street could use a jolt to get out of its early-year funk. … Continue reading Will Q4 Earnings Give Stocks Another Boost?